Prevention of ICU delirium and delirium-related outcome with haloperidol: A study protocol for a multicenter randomized controlled trial

Trials

Volumn 14, Issue 1, 2013, Pages

  van den Boogaard, Mark ^a   Slooter, Arjen J ^b   Brüggemann, Roger J M ^a   Schoonhoven, Lisette ^a   Kuiper, Michael A ^c   van der Voort, Peter H J ^d   Hoogendoorn, Marga E ^e   Beishuizen, Albert ^f   Schouten, Jeroen A ^g   Spronk, Peter E ^h   Houterman, Saskia ⁱ   van der Hoeven, Johannes G ^a   Pickkers, Peter ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c MEDICAL CENTER LEEUWARDEN   (Netherlands)

^d Onze Lieve Vrouwe Gasthuis ^*  (Netherlands)

^e Research Department of Anesthesiology and Intensive Care   (Netherlands)

^f MEDISCH SPECTRUM TWENTE   (Netherlands)

^g CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^h GELRE HOSPITALS   (Netherlands)

ⁱ CATHARINA HOSPITAL   (Netherlands)

Author keywords

Critically ill; Delirium; Haloperidol; Intensive care; Mortality; Prevention; Prophylaxis; Randomized trial

Indexed keywords

HALOPERIDOL; PLACEBO;

ADULT; ARTICLE; CLINICAL PROTOCOL; CRITICALLY ILL PATIENT; DELIRIUM; DRUG SAFETY; FOLLOW UP; HUMAN; INTENSIVE CARE; INTERVENTION STUDY; LENGTH OF STAY; MORTALITY; MULTICENTER STUDY (TOPIC); PATIENT MONITORING; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SURVIVAL RATE;

DATA COLLECTION; DELIRIUM; DOUBLE-BLIND METHOD; ETHICS, MEDICAL; HALOPERIDOL; HUMANS; INTENSIVE CARE UNITS; PROPORTIONAL HAZARDS MODELS; SAMPLE SIZE; TREATMENT OUTCOME;

EID: 84887878813     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-14-400     Document Type: Article

References (37)

1. Association AP. Diagnostic and statistical manual of mental disorders (DSM-V) 2013, Arlington, VA: American Psychiatric Publishing.
2. Dubois MJ, Bergeron N, Dumont M, Dial S, Skrobik Y. Delirium in an intensive care unit: a study of risk factors. Intensive Care Med 2001, 27:1297-1304. 10.1007/s001340101017, 11511942.
3. American college of chest physicians/society of critical care medicine consensus conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20:864-874. 10.1097/00003246-199206000-00025, 1597042.
4. Ely EW, Gautam S, Margolin R, Francis J, May L, Speroff T, Truman B, Dittus R, Bernard R, Inouye SK. The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med 2001, 27:1892-1900. 10.1007/s00134-001-1132-2, 11797025.
5. Ouimet S, Kavanagh BP, Gottfried SB, Skrobik Y. Incidence, risk factors and consequences of ICU delirium. Intensive Care Med 2007, 33:66-73. 10.1007/s00134-006-0399-8, 17102966.
6. van den Boogaard M, Schoonhoven L, van der Hoeven JG, van Achterberg T, Pickkers P. Incidence and short-term consequences of delirium in critically ill patients: a prospective observational cohort study. Int J Nurs Stud 2012, 49:775-783. 10.1016/j.ijnurstu.2011.11.016, 22197051.
7. van den Boogaard M, Peters SA, van der Hoeven JG, Dagnelie PC, Leffers P, Pickkers P, Schoonhoven L. The impact of delirium on the prediction of in-hospital mortality in intensive care patients. Crit Care 2010, 14:R146. 10.1186/cc9214, 2945129, 20682037.
8. Ely EW, Shintani A, Truman B, Speroff T, Gordon SM, Harrell FE, Inouye SK, Bernard GR, Dittus R. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. J Amer Med Assoc 2004, 292:168-169.
9. van den Boogaard M, Schoonhoven L, Evers AW, van der Hoeven JG, van Achterberg T, Pickkers P. Delirium in critically ill patients: impact on long-term health-related quality of life and cognitive functioning. Crit Care Med 2012, 40:112-118. 10.1097/CCM.0b013e31822e9fc9, 21926597.
10. Girard TD, Jackson JC, Pandharipande PP, Pun BT, Thompson JL, Shintani AK, Gordon SM, Canonico AE, Dittus RS, Bernard GR, Ely EW. Delirium as a predictor of long-term cognitive impairment in survivors of critical illness. Crit Care Med 2010, 38:1513-1520. 10.1097/CCM.0b013e3181e47be1, 3638813, 20473145.
11. Kalisvaart KJ, de Jonghe JF, Bogaards MJ, Vreeswijk R, Egberts TC, Burger BJ, Eikelenboom P, van Gool WA. Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium: a randomized placebo-controlled study. J Am Geriatr Soc 2005, 53:1658-1666. 10.1111/j.1532-5415.2005.53503.x, 16181163.
12. Kaneko T, Cai J, Ishikura T, Kobayashi M, Naka T, Kaibara N. Prophylactic consecutive administration of haloperidol can reduce the occurrence of postoperative delirium in gastrointestinal surgery. Yonago Acta Med 1999, 42:179-184.
13. Prakanrattana U, Prapaitrakool S. Efficacy of risperidone for prevention of postoperative delirium in cardiac surgery. Anaesth Intensive Care 2007, 35:714-719.
14. Gamberini M, Bolliger D, Lurati Buse GA, Burkhart CS, Grapow M, Gagneux A, Filipovic M, Seeberger MD, Pargger H, Siegemund M, Carrel T, Seiler WO, Berres M, Strebel SP, Monsch AU, Steiner LA. Rivastigmine for the prevention of postoperative delirium in elderly patients undergoing elective cardiac surgery-a randomized controlled trial. Crit Care Med 2009, 37:1762-1768. 10.1097/CCM.0b013e31819da780, 19325490.
15. Girard TD, Pandharipande PP, Carson SS, Schmidt GA, Wright PE, Canonico AE, Pun BT, Thompson JL, Shintani AK, Meltzer HY, Bernard GR, Dittus RS, Ely EW,. MIND Trial Investigators Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial. Crit Care Med 2010, 38:428-437. 10.1097/CCM.0b013e3181c58715, 3645269, 20095068, MIND Trial Investigators.
16. Milbrandt EB, Kersten A, Kong L, Weissfeld LA, Clermont G, Fink MP, Angus DC. Haloperidol use is associated with lower hospital mortality in mechanically ventilated patients. Crit Care Med 2005, 33:226-229. 10.1097/01.CCM.0000150743.16005.9A, 15644675.
17. Wang W, Li HL, Wang DX, Zhu X, Li SL, Yao GQ, Chen KS, Gu XE, Zhu SN. Haloperidol prophylaxis decreases delirium incidence in elderly patients after noncardiac surgery: a randomized controlled trial. Crit Care Med 2012, 40:1-9.
18. van den Boogaard M, Pickkers P, Slooter AJ, Kuiper MA, Spronk PE, van D, van der Hoeven JG, Donders R, van AT, Schoonhoven L. Development and validation of PRE-DELIRIC (PREdiction of DELIRium in ICu patients) delirium prediction model for intensive care patients: observational multicentre study. BMJ 2012, 344:e420-e420. 10.1136/bmj.e420, 3276486, 22323509.
19. van den Boogaard M, Schoonhoven L, Van Achterberg T, Van der Hoeven JG, Pickkers P. Haloperidol prophylaxis in critically ill patients with a high risk for delirium. Crit Care 2013, 17:R9. 10.1186/cc11933, 23327295.
20. de Smet AM, Kluytmans JA, Cooper BS, Mascini EM, Benus RF, van der Werf TS, van der Hoeven JG, Pickkers P, Bogaers-Hofman D, van der Meer NJ, Bernards AT, Kuijper EJ, Joore JC, Leverstein-van Hall MA, Bindels AJ, Jansz AR, Wesselink RM, de Jongh BM, Dennesen PJ, van Asselt GJ, te Velde LF, Frenay IH, Kaasjager K, Bosch FH, van Iterson M, Thijsen SF, Kluge GH, Pauw W, de Vries JW, Kaan JA, et al. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 2009, 360:20-31. 10.1056/NEJMoa0800394, 19118302.
21. Heyland DK, Dhaliwal R, Jiang X, Day AG. Identifying critically ill patients who benefit the most from nutrition therapy: the development and initial validation of a novel risk assessment tool. Crit Care 2011, 15:R268. 10.1186/cc10546, 3388687, 22085763.
22. Ginwalla M, Biblo LA, Paydak H. Torsade de pointes following intravenous haloperidol administration in a patient with complete heart block. WMJ 2009, 108:48-50.
23. O'Brien JM, Rockwood RP, Suh KI. Haloperidol-induced torsade de pointes. Ann Pharmacother 1999, 33:1046-1050. 10.1345/aph.19017, 10534216.
24. Perrault LP, Denault AY, Carrier M, Cartier R, Belisle S. Torsades de Pointes secondary to intravenous haloperidol after coronary bypass grafting surgery. Can J Anaesth 2000, 47:251-254. 10.1007/BF03018922, 10730737.
25. Sharma ND, Rosman HS, Padhi ID, Tisdale JE. Torsades de Pointes associated with intravenous haloperidol in critically ill patients. Am J Cardiol 1998, 81:238-240. 10.1016/S0002-9149(97)00888-6, 9591913.
26. Moher D, Schulz KF, Altman DG. Consort: the CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials. BMC Med Res Methodol 2001, 1:2. 10.1186/1471-2288-1-2, 32201, 11336663.
27. Ely EW, Inouye SK, Bernard GR, Gordon S, Francis J, May L, Truman B, Speroff T, Gautam S, Margolin R, Hart RP, Dittus R. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA 2001, 286:2703-2710. 10.1001/jama.286.21.2703, 11730446.
28. Ely EW, Margolin R, Francis J, May L, Truman B, Dittus R, Speroff T, Gautam S, Bernard GR, Inouye SK. Evaluation of delirium in critically ill patients: validation of the confusion assessment method for the intensive care unit (CAM-ICU). Crit Care Med 2001, 29:1370-1379. 10.1097/00003246-200107000-00012, 11445689.
29. Vreeswijk R, Toornvliet A, Honing MLH, Bakker K, de Man T, Daas G, Spronk P, de Jonghe JF, Kalisvaart KJ. Validation of the Dutch version of the confusion assessment method (CAM-ICU) for delirium screening in the intensive care unit. Netherlands Journal of Critical Care 2009, 13:73-78.
30. Schuurmans MJ, Shortridge-Baggett LM, Duursma SA. The delirium observation screening scale: a screening instrument for delirium. Res Theory Nurs Pract 2003, 17:31-50. 10.1891/rtnp.17.1.31.53169, 12751884.
31. Abdo WF, van de Warrenburg BP, Burn DJ, Quinn NP, Bloem BR. The clinical approach to movement disorders. Nat Rev Neurol 2010, 6:29-37. 10.1038/nrneurol.2009.196, 20057497.
32. Barr J, Fraser GL, Puntillo K, Ely EW, Gelinas C, Dasta JF, Davidson JE, Devlin JW, Kress JP, Joffe AM, Coursin DB, Herr DL, Tung A, Robinson BR, Fontaine DK, Ramsay MA, Riker RR, Sessler CN, Pun B, Skrobik Y, Jaeschke R,. American College of Critical Care Medicine Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 2013, 41:263-306. American College of Critical Care Medicine.
33. Schweickert WD, Pohlman MC, Pohlman AS, Nigos C, Pawlik AJ, Esbrook CL, Spears L, Miller M, Franczyk M, Deprizio D, Schmidt GA, Bowman A, Barr R, McCallister KE, Hall JB, Kress JP. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet 2009, 373:1874-1882. 10.1016/S0140-6736(09)60658-9, 19446324.
34. Kompas F. Farmacotherapeutisch Kompas 2012 2012, Amstelveen: Prelum Uitgevers.
35. Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, Bullinger M, Kaasa S, Leplege A, Prieto L, Sullivan M. Cross-validation of item selection and scoring for the SF-12 health survey in nine countries: results from the IQOLA project. International Quality of Life Assessment. J Clin Epidemiol 1998, 51:1171-1178. 10.1016/S0895-4356(98)00109-7, 9817135.
36. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979, 35:549-556. 10.2307/2530245, 497341.
37. Heymann A, Radtke F, Schiemann A, Lutz A, MacGuill M, Wernecke KD, Spies C. Delayed treatment of delirium increases mortality rate in intensive care unit patients. J Int Med Res 2010, 38:1584-1595. 10.1177/147323001003800503, 21309472.